Navigation Links
Rare Cancer- Subject of Study

Physicians at Wake Forest University Baptist Medical Center have developed new techniques that assist in the easy diagnosis of rare cancers. They published the results// of their study in the American Journal of Surgical Pathology. Robert F. Bradley, M.D said that tumors of the appendix that have metastasized through the abdominal cavity are all referred to as cancer. Bradley, a pathology resident, and colleagues studied 101 patients with pseudomyxoma peritonei, a rare form of cancer of the lining of the abdominal cavity. The cancer produces mucin, a jelly-like substance begins in the appendix or colon and spreads to the abdominal lining.

Wake Forest is one of a few centers in the country that offers surgery to remove the tumor and then infusion of heated chemotherapy drugs into the abdominal cavity. This type of cancer is rare and the treatment includes removal of appendices. After this the sections of the tumor are studied and classified it into three general categories: high-grade cancer, low-grade cancer, and benign. But patients in all the three groups are subjected to the same treatment. The classification is mainly to indicate the type of response generated by the patient. Patients from 1993 to 2005 were treated and found one-year, three-year and five-year survival rates were not significantly different for patients in the low-grade cancer and benign categories.

But those in the high-grade category had significantly worse survival. It is seen that there is no separate benign category but physicians should expect it to behave like low-grade cancer. If it is properly treated then it has a favorable prognosis. In conclusion he said that surgery plus abdominal chemotherapy known as intraperitoneal hyperthermic chemotherapy (IPHC) together is used in the treatment of tumors that had spread from the appendix, small bowels, ovaries, colon, rectum and stomach has improved the overall survival and quality of life.
'"/>




Page: 1

Related medicine news :

1. Protein acts as "Master Switch" that cuts off cells Cancer-Growth machinery
2. Cancer-causing Property Of Teflon Leaves US Regulators Concerned
3. Now A Cancer-Fighting Tomato
4. Cancer-Causing Virus Synthesizes Protein To Help Sustain Itself In Host Cells
5. New Cancer-Blocking Algae Found
6. Cancer-Killing Compound From A Fungus
7. Cancer-Killing Viruses Employ Multiple Mechanisms
8. Arimidex-Herceptin Combo Therapy For Breast Cancer-Clinical Trial Findings
9. Head and Neck Cancer-Taxotere Approved
10. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
11. Genes That Allow Brain Cancer-Causing Stem Cells to Resist Treatment Identified
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... ... December 08, 2016 , ... Vida Health, the digital ... B led by Canvas Ventures . Other investors include Nokia Growth Partners (NGP) ... platform to serve more consumers who are managing chronic conditions or simply ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... from offices headquartered in Jefferson County, is announcing the launch of a charity ... , The number of homeless women and children in Birmingham has grown steadily ...
(Date:12/8/2016)... St. Louis, MS (PRWEB) , ... December 08, 2016 , ... ... offices that serve commercial and residential clients in and around the Hancock County area, ... support for the Hancock County Food Pantry. , The Hancock County Food Pantry has ...
(Date:12/7/2016)... KING OF PRUSSIA, PA (PRWEB) , ... December 07, 2016 , ... ... of clinical trials with the announcement that it is one of the early adopters ... EU-U.S. Privacy Shield Framework is designed to provide companies on both sides of the ...
(Date:12/7/2016)... ... ... Kenall Manufacturing, a leader in sealed healthcare lighting for more than 30 ... sealed, LED luminaire that meets the needs of everyone in the patient room by ... , A 2’ x 4’ model features four modes: reading, ambient, standard and high ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)...  Hanson Research, an innovative leader in the ... testing instruments for the pharmaceutical industry, announced today ... ("Teledyne"). The move is designed to deepen investments ... as well as expand resources for further market ... services. Logo - http://photos.prnewswire.com/prnh/20161208/446988LOGO ...
(Date:12/8/2016)... Dec. 8, 2016 Augmedix, the nation,s ... it has closed a $23 million strategic round ... OrbiMed. The company seeks to rehumanize the physician ... on mandated EHR documentation. The Augmedix core offering ... frees doctors from 3 hours of mandated charting ...
(Date:12/8/2016)... N.J., Dec. 8, 2016 CANTEL MEDICAL CORP. (NYSE: ... of $18,800,000, or $0.45 per diluted share, on a 22.1% ... quarter ended October 31, 2016. This compares with net income ... $153,779,000 for the first quarter ended October 31, 2015. ... quarter ended October 31, 2016 to $21,323,000, or $0.51 per ...
Breaking Medicine Technology: